Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
Clicks: 682
ID: 87889
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
71.7
/100
682 views
505 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 3 articles by views in Системные гипертензии
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Objective. To study the possibility of the 2D Speckle Tracking Imaging in early detection of cardiotoxicity in patients with triple negative breast cancer and arterial hypertension (AH) during anthracycline-containing chemotherapy.
Materials and methods. 70 women (mean age 48.6±13.3 years) with triple negative breast cancer were enrolled. All patients underwent chemotherapy, including anthracycline, taxan, platinum-based agent. Echocardiography, including 2D Speckle Tracking Imaging, was performed on Vivid-E 9 ultrasound machine before and after 8 weeks of chemotherapy. Left ventricular ejection fraction (LVEF) (the biplane Simpson`s method) and global longitudinal strain (GLS) (mean normal GLS of -22.1±1.8 for women) were analysed. Patients were divided into two groups: group 1 – with AH (n=18) and group 2 – with normal blood pressure (n=52).
Results. Before chemotherapy in group 1 GLS was lower than normal value (-19.1±2.8% vs -22.1±1.8%; p<0.05) and lower than in the group 2 (-19.1±2.8% vs -20.0±2.8%; p>0.05). After chemotherapy in all patients GLS decrease was observed from -20.0±2.8% to -18.5±2.9% (p<0.05) and in group 1 from -19.1±2.8% to -16.4±3.8% (р<0.05), group 2 from -20.0±2.8% to -19.2±2.4% (p<0.05). However LVEF remained within normal values. The values of GLS decreased by more than 15% in 12 (17%) of all the patients.
Conclusions. Apparently, GLS is the one of most sensitive early marker of chemotherapy – induced cardiotoxicity compared with the LVEF.
| Reference Key |
aa2017markers
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | A.A., Avalyan;M.Yu., Kirillova;V.N., Shitov; |
| Journal | Системные гипертензии |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.